Noticias de AGEN_US

Noticias del mercado

Últimas noticias sobre AGEN_US — 157 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AGEN_US ✕ 157 resultados
26/03/2026 AGEN_US — Stock Titan
[SCHEDULE 13G/A] AGENUS INC Amended Passive Investment Disclosure
26/03/2026 AGEN_US — Stock Titan
Court dismisses Agenus (AGEN) securities class action, siding with executives
26/03/2026 AGEN_US — Stock Titan ES ← EN
Agenus detallará el progreso del programa contra el cáncer y el acceso de los pacientes el 31 de marzo
26/03/2026 AGEN_US — Investing.com
Agenus reports dismissal of securities class action lawsuit in Massachusetts
26/03/2026 AGEN_US — TipRanks
Agenus Securities Class Action Dismissed, Legal Risks Ease
25/03/2026 AGEN_US — Bloomberg Law News
Agenus Secures Dismissal of Investors’ Cancer Drug Class Action
24/03/2026 AGEN_US — MSN ES ← EN
Vista previa de las ganancias del cuarto trimestre de 2025 de Agenus
24/03/2026 AGEN_US — Law360
Agenus Escapes Investor Fraud Suit Over Cancer Drug
24/03/2026 AGEN_US — Stock Titan
Agenus (NASDAQ: AGEN) director Armen paid salary in stock grant
18/03/2026 AGEN_US — BioSpace
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
17/03/2026 AGEN_US — Yahoo Finance
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
17/03/2026 AGEN_US — Investing.com
Agenus stock price target reaffirmed at $8 by B.Riley on revenue growth
16/03/2026 AGEN_US — 10tv.com ES ← EN
Agenus: Resumen de ganancias del cuarto trimestre
16/03/2026 AGEN_US — Yahoo Finance
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
16/03/2026 AGEN_US — Business Wire
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
16/03/2026 AGEN_US — Quiver Quantitative
Agenus Inc. (AGEN) Releases Q4 2025 Earnings: Revenue Up but Wider Net Loss, Cash Plunges
16/03/2026 AGEN_US — Yahoo Finance
Agenus (AGEN) Q4 Earnings and Revenues Surpass Estimates
16/03/2026 AGEN_US — Stock Titan
Agenus (AGEN) secures Zydus funding as BOT+BAL enters global Phase 3
16/03/2026 AGEN_US — Investing.com
Agenus reports $4.2M in early access revenue for cancer therapy
16/03/2026 AGEN_US — Oncodaily
Agenus Reports 2025 Progress: BOT+BAL Immunotherapy Advances to Phase 3 with Global Early Access Programs

Página 7 de 8

keyboard_arrow_up